{"transactions":[{"id":808428,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-04-15T20:20:14.000Z","date":"2026-04-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":946,"price":4.91,"value":4644.86,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on April 14, 2026."}],"balance_after":326310,"source":{"system":"sec-edgar","filing":"0001922964-26-000010","document":"wk-form4_1776284411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296426000010/wk-form4_1776284411.xml","form_type":"4"}},{"id":831493,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-23T20:23:03.000Z","date":"2026-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":2019,"price":4.58,"value":9247.02,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 20, 2026."}],"balance_after":327256,"source":{"system":"sec-edgar","filing":"0001922964-26-000008","document":"wk-form4_1774297381.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296426000008/wk-form4_1774297381.xml","form_type":"4"}},{"id":842668,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:06:03.000Z","date":"2026-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":11949,"price":4.66,"value":55682.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of the Issuer's Common Stock on March 13, 2026."}],"balance_after":329275,"source":{"system":"sec-edgar","filing":"0001922964-26-000006","document":"wk-form4_1773695160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296426000006/wk-form4_1773695160.xml","form_type":"4"}},{"id":842667,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:06:03.000Z","date":"2026-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":4783,"price":4.66,"value":22288.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026."}],"balance_after":341224,"source":{"system":"sec-edgar","filing":"0001922964-26-000006","document":"wk-form4_1773695160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296426000006/wk-form4_1773695160.xml","form_type":"4"}},{"id":842666,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:06:03.000Z","date":"2026-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":8288,"price":4.66,"value":38622.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026."}],"balance_after":346007,"source":{"system":"sec-edgar","filing":"0001922964-26-000006","document":"wk-form4_1773695160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296426000006/wk-form4_1773695160.xml","form_type":"4"}},{"id":842665,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:06:03.000Z","date":"2026-03-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":12779,"price":4.66,"value":59550.14,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of Common Stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted stock units previously granted to the Reporting Person. The number of shares withheld was determined based on the closing price of Issuer's Common Stock on March 13, 2026."}],"balance_after":354295,"source":{"system":"sec-edgar","filing":"0001922964-26-000006","document":"wk-form4_1773695160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296426000006/wk-form4_1773695160.xml","form_type":"4"}},{"id":842664,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-03-16T21:06:03.000Z","date":"2026-03-12","kind":"grant","planned":false,"acquired":true,"shares":173196,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Issuer's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":367074,"source":{"system":"sec-edgar","filing":"0001922964-26-000006","document":"wk-form4_1773695160.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296426000006/wk-form4_1773695160.xml","form_type":"4"}},{"id":922971,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-02-03T22:30:03.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":23697,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance-based restricted stock units (PSUs) initially granted on March 15, 2023, subject to accomplishment of pre-determined performance metrics. On February 2, 2026, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 15, 2026."}],"balance_after":193878,"source":{"system":"sec-edgar","filing":"0001922964-26-000004","document":"wk-form4_1770157800.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296426000004/wk-form4_1770157800.xml","form_type":"4"}},{"id":955762,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2026-01-02T21:17:40.000Z","date":"2026-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":418,"price":6.15,"value":2570.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on December 31, 2025."}],"balance_after":170181,"source":{"system":"sec-edgar","filing":"0001922964-26-000002","document":"wk-form4_1767388657.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296426000002/wk-form4_1767388657.xml","form_type":"4"}},{"id":1172162,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-04-15T20:14:36.000Z","date":"2025-04-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":942,"price":8.08,"value":7611.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on April 14, 2025."}],"balance_after":170599,"source":{"system":"sec-edgar","filing":"0001922964-25-000004","document":"wk-form4_1744748070.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296425000004/wk-form4_1744748070.xml","form_type":"4"}},{"id":1192722,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-03-25T20:16:49.000Z","date":"2025-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":800,"price":9.98,"value":7984.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025."}],"balance_after":171541,"source":{"system":"sec-edgar","filing":"0001628280-25-014726","document":"wk-form4_1742933802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025014726/wk-form4_1742933802.xml","form_type":"4"}},{"id":1192721,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-03-25T20:16:49.000Z","date":"2025-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":545,"price":9.98,"value":5439.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2025."}],"balance_after":172341,"source":{"system":"sec-edgar","filing":"0001628280-25-014726","document":"wk-form4_1742933802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025014726/wk-form4_1742933802.xml","form_type":"4"}},{"id":1192720,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-03-25T20:16:49.000Z","date":"2025-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":5334,"price":10.01,"value":53393.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 21, 2025."}],"balance_after":172886,"source":{"system":"sec-edgar","filing":"0001628280-25-014726","document":"wk-form4_1742933802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025014726/wk-form4_1742933802.xml","form_type":"4"}},{"id":1192719,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-03-25T20:16:49.000Z","date":"2025-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":2011,"price":10.01,"value":20130.11,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 21, 2025."}],"balance_after":178220,"source":{"system":"sec-edgar","filing":"0001628280-25-014726","document":"wk-form4_1742933802.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025014726/wk-form4_1742933802.xml","form_type":"4"}},{"id":1204841,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-03-17T20:19:58.000Z","date":"2025-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":4764,"price":10.07,"value":47973.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 14, 2025."}],"balance_after":180231,"source":{"system":"sec-edgar","filing":"0001628280-25-013149","document":"wk-form4_1742242790.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025013149/wk-form4_1742242790.xml","form_type":"4"}},{"id":1204840,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-03-17T20:19:58.000Z","date":"2025-03-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":8544,"price":10.07,"value":86038.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 14, 2025."}],"balance_after":184995,"source":{"system":"sec-edgar","filing":"0001628280-25-013149","document":"wk-form4_1742242790.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025013149/wk-form4_1742242790.xml","form_type":"4"}},{"id":1204839,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-03-17T20:19:58.000Z","date":"2025-03-13","kind":"grant","planned":false,"acquired":true,"shares":75773,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":193539,"source":{"system":"sec-edgar","filing":"0001628280-25-013149","document":"wk-form4_1742242790.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025013149/wk-form4_1742242790.xml","form_type":"4"}},{"id":1232255,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-03-05T00:31:31.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":10622,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance-based restricted stock units (PSUs) initially granted on March 22, 2022, subject to accomplishment of pre-determined performance metrics. On February 7, 2025, the Compensation and Human Capital Committee of the Company's Board of Directors determined the final award amount based on the accomplishment of the applicable performance metrics. Each PSU represents a contingent right to receive one share of the Company's common stock and vests on March 22, 2025."}],"balance_after":117766,"source":{"system":"sec-edgar","filing":"0001628280-25-010137","document":"wk-form4_1741134685.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828025010137/wk-form4_1741134685.xml","form_type":"4"}},{"id":1319087,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2025-01-02T21:26:38.000Z","date":"2025-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":417,"price":13.71,"value":5717.07,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on December 31, 2024."}],"balance_after":107144,"source":{"system":"sec-edgar","filing":"0001922964-25-000002","document":"wk-form4_1735853189.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296425000002/wk-form4_1735853189.xml","form_type":"4"}},{"id":1388307,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-10-10T20:33:11.000Z","date":"2024-10-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":452,"price":24.37,"value":11015.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 9, 2024."}],"balance_after":107561,"source":{"system":"sec-edgar","filing":"0001922964-24-000008","document":"wk-form4_1728592385.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296424000008/wk-form4_1728592385.xml","form_type":"4"}},{"id":1409164,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-09-12T20:09:19.000Z","date":"2024-09-11","kind":"sale","planned":false,"acquired":false,"shares":2100,"price":26.172,"value":54961.2,"ownership":{"direct":true},"balance_after":108013,"source":{"system":"sec-edgar","filing":"0001922964-24-000006","document":"wk-form4_1726171753.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296424000006/wk-form4_1726171753.xml","form_type":"4"}},{"id":1542216,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-04-15T20:27:13.000Z","date":"2024-04-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":940,"price":19.55,"value":18377.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on April 12, 2024."}],"balance_after":110113,"source":{"system":"sec-edgar","filing":"0001922964-24-000004","document":"wk-form4_1713212823.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296424000004/wk-form4_1713212823.xml","form_type":"4"}},{"id":1562548,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-03-25T20:31:19.000Z","date":"2024-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":561,"price":22.24,"value":12476.64,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024."}],"balance_after":111053,"source":{"system":"sec-edgar","filing":"0001628280-24-012916","document":"wk-form4_1711398666.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828024012916/wk-form4_1711398666.xml","form_type":"4"}},{"id":1562547,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-03-25T20:31:19.000Z","date":"2024-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":382,"price":22.24,"value":8495.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024."}],"balance_after":111614,"source":{"system":"sec-edgar","filing":"0001628280-24-012916","document":"wk-form4_1711398666.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828024012916/wk-form4_1711398666.xml","form_type":"4"}},{"id":1562546,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-03-25T20:31:19.000Z","date":"2024-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":1405,"price":22.24,"value":31247.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2024."}],"balance_after":111996,"source":{"system":"sec-edgar","filing":"0001628280-24-012916","document":"wk-form4_1711398666.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828024012916/wk-form4_1711398666.xml","form_type":"4"}},{"id":1573560,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-03-18T20:45:24.000Z","date":"2024-03-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":3322,"price":21.16,"value":70293.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 15, 2024."}],"balance_after":113401,"source":{"system":"sec-edgar","filing":"0001628280-24-011682","document":"wk-form4_1710794714.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828024011682/wk-form4_1710794714.xml","form_type":"4"}},{"id":1573559,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-03-18T20:45:24.000Z","date":"2024-03-14","kind":"grant","planned":false,"acquired":true,"shares":49250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":116723,"source":{"system":"sec-edgar","filing":"0001628280-24-011682","document":"wk-form4_1710794714.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828024011682/wk-form4_1710794714.xml","form_type":"4"}},{"id":1697067,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2024-01-02T22:52:01.000Z","date":"2024-01-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":303,"price":19.14,"value":5799.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on December  29, 2023."}],"balance_after":67473,"source":{"system":"sec-edgar","filing":"0001922964-24-000002","document":"wk-form4_1704235912.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296424000002/wk-form4_1704235912.xml","form_type":"4"}},{"id":1762968,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-10-10T20:15:44.000Z","date":"2023-10-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":308,"price":15.01,"value":4623.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 9, 2023."}],"balance_after":67776,"source":{"system":"sec-edgar","filing":"0001922964-23-000008","document":"wk-form4_1696968933.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296423000008/wk-form4_1696968933.xml","form_type":"4"}},{"id":1772855,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-09-27T20:18:09.000Z","date":"2023-09-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":133,"price":15.99,"value":2126.67,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 26, 2023."}],"balance_after":68084,"source":{"system":"sec-edgar","filing":"0001922964-23-000006","document":"wk-form4_1695845879.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296423000006/wk-form4_1695845879.xml","form_type":"4"}},{"id":1919196,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-04-17T22:20:34.000Z","date":"2023-04-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":638,"price":22.27,"value":14208.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on April 14, 2023."}],"balance_after":68217,"source":{"system":"sec-edgar","filing":"0001922964-23-000003","document":"wf-form4_168177002190556.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296423000003/wf-form4_168177002190556.xml","form_type":"4"}},{"id":1938403,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-03-27T20:28:31.000Z","date":"2023-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":545,"price":23.72,"value":12927.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of performance-based restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023."}],"balance_after":68855,"source":{"system":"sec-edgar","filing":"0001628280-23-009264","document":"wf-form4_167994889776174.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828023009264/wf-form4_167994889776174.xml","form_type":"4"}},{"id":1938402,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-03-27T20:28:31.000Z","date":"2023-03-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":372,"price":23.72,"value":8823.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 24, 2023."}],"balance_after":69400,"source":{"system":"sec-edgar","filing":"0001628280-23-009264","document":"wf-form4_167994889776174.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828023009264/wf-form4_167994889776174.xml","form_type":"4"}},{"id":1940673,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-03-23T20:29:29.000Z","date":"2023-03-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":1399,"price":22.91,"value":32051.09,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on March 22, 2023."}],"balance_after":69772,"source":{"system":"sec-edgar","filing":"0001628280-23-009052","document":"wf-form4_167960335731267.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828023009052/wf-form4_167960335731267.xml","form_type":"4"}},{"id":1950940,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-03-16T20:30:45.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":28459,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":71171,"source":{"system":"sec-edgar","filing":"0001628280-23-008320","document":"wf-form4_167899860209122.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828023008320/wf-form4_167899860209122.xml","form_type":"4"}},{"id":2070212,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2023-01-04T23:09:17.000Z","date":"2023-01-01","kind":"tax_withholding","acquired":false,"shares":302,"price":14.51,"value":4382.02,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on December 30, 2022."}],"balance_after":42712,"source":{"system":"sec-edgar","filing":"0001922964-23-000001","document":"wf-form4_167287373358897.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296423000001/wf-form4_167287373358897.xml","form_type":"4"}},{"id":2139699,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-10-11T20:36:18.000Z","date":"2022-10-09","kind":"tax_withholding","acquired":false,"shares":309,"price":19.62,"value":6062.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on October 7, 2022."}],"balance_after":43014,"source":{"system":"sec-edgar","filing":"0001628280-22-026254","document":"wf-form4_166552056246727.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828022026254/wf-form4_166552056246727.xml","form_type":"4"}},{"id":2150767,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-09-27T20:31:36.000Z","date":"2022-09-26","kind":"tax_withholding","acquired":false,"shares":133,"price":18.41,"value":2448.53,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 26, 2022."}],"balance_after":43323,"source":{"system":"sec-edgar","filing":"0001628280-22-025564","document":"wf-form4_166431067555459.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828022025564/wf-form4_166431067555459.xml","form_type":"4"}},{"id":2150766,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-09-27T20:31:36.000Z","date":"2022-09-25","kind":"tax_withholding","acquired":false,"shares":345,"price":18.69,"value":6448.05,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 23, 2022."}],"balance_after":43456,"source":{"system":"sec-edgar","filing":"0001628280-22-025564","document":"wf-form4_166431067555459.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000162828022025564/wf-form4_166431067555459.xml","form_type":"4"}},{"id":2297321,"issuer":{"id":5953,"kind":"organization","name":"MYRIAD GENETICS INC","symbol":"MYGN"},"owners":[{"id":52468,"kind":"person","name":"Muzzey Dale","position":1,"cik":"0001922964","reported_name":"Muzzey Dale","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2022-04-14T21:07:07.000Z","date":"2022-04-14","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Consists of time-based restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":43801,"source":{"system":"sec-edgar","filing":"0001922964-22-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/899923/000192296422000004/edgardoc.xml","form_type":"4"}}]}